Irbesartan Zentiva 150 mg tablets
Authorisation EU/1/06/376/6-10 · Zentiva k.s.
- Licence holder
- Zentiva k.s. (all products →)
- Active substance
- Irbesartan
- Clinical trials
- 4 clinical trials →
- Dosage form
- Tablet
- Route of administration
- Oral use
- ATC codes
- C09CA, C09CA04
- First authorised
- 19/01/2007
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Informed consent application (Article 10c of Directive No 2001/83/EC)
Irbesartan: supply and approvals
51 authorised products on the HPRA list contain Irbesartan. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 19 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 19 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 19 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
Centralised EU authorisation. This product holds an EU-wide marketing authorisation granted by the European Commission after assessment by the European Medicines Agency, valid in every EU country. Its EU product number is 376. It has been authorised for 19 years (since 19 January 2007). The HPRA list does not say whether it is on sale.
Other medicines with Irbesartan in Ireland
50 other products on the HPRA list contain Irbesartan, from 8 licence holders; 6 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Irbesartan Clonmel 150 mg film-coated tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Irbesartan Clonmel 300 mg film-coated tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Irbesartan Clonmel 75 mg film-coated tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Irbesartan Rowa 150 mg tablets | Rowa Pharmaceuticals Limited, | National authorisation (PA) | Marketed |
| Irbesartan Rowa 300 mg tablets | Rowa Pharmaceuticals Limited, | National authorisation (PA) | Marketed |
| Irbesartan Rowa 75 mg tablets | Rowa Pharmaceuticals Limited, | National authorisation (PA) | Marketed |
| Aprovel 150 mg film-coated tablets | Sanofi Winthrop Industrie | Centralised EU authorisation | Not stated |
| Aprovel 150 mg tablets | Sanofi Winthrop Industrie | Centralised EU authorisation | Not stated |
| Aprovel 300 mg film-coated tablets | Sanofi Winthrop Industrie | Centralised EU authorisation | Not stated |
| Aprovel 300 mg tablets | Sanofi Winthrop Industrie | Centralised EU authorisation | Not stated |
| Aprovel 75 mg film-coated tablets | Sanofi Winthrop Industrie | Centralised EU authorisation | Not stated |
| Aprovel 75 mg tablets | Sanofi Winthrop Industrie | Centralised EU authorisation | Not stated |
Other substances in ATC group C09CA
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 9 other active substances share the group C09CA with this product:
Telmisartan (34) · Valsartan (26) · Candesartan cilexetil (21) · Losartan potassium (18) · Olmesartan medoxomil (18) · Hydrochlorothiazide (4) · Azilsartan medoxomil (3) · Eprosartan (3) · Hydrocholothiazide (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Zentiva k.s. holds 68 products on the HPRA list, with 28 different active substances; 17 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 20 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.